(Lauren Neergard/ CBC MNews) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.

Eli Lilly and Co. is seeking U.S. Food and Drug Administration (FDA) approval of donanemab. If cleared, it would be only the  …

(Tasmiha Khan/ Health) —  The U.S. Food and Drug Administration is warning patients who have breast implants or are considering getting them of additional cancers linked to implants, according to an FDA Safety Communication issued Thursday.

The cancers—squamous cell carcinoma (SCC) and various lymphomas—are  …